HomeCompareWMMCX vs MRK

WMMCX vs MRK: Dividend Comparison 2026

WMMCX yields 20.82% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WMMCX wins by $20.0K in total portfolio value
10 years
WMMCX
WMMCX
● Live price
20.82%
Share price
$11.38
Annual div
$2.37
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$76.8K
Annual income
$7,349.60
Full WMMCX calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — WMMCX vs MRK

📍 WMMCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWMMCXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WMMCX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WMMCX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WMMCX
Annual income on $10K today (after 15% tax)
$1,769.84/yr
After 10yr DRIP, annual income (after tax)
$6,247.16/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $2,081.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WMMCX + MRK for your $10,000?

WMMCX: 50%MRK: 50%
100% MRK50/50100% WMMCX
Portfolio after 10yr
$66.8K
Annual income
$8,573.87/yr
Blended yield
12.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WMMCX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WMMCX buys
0
MRK buys
0
No recent congressional trades found for WMMCX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWMMCXMRK
Forward yield20.82%2.76%
Annual dividend / share$2.37$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$76.8K$56.8K
Annual income after 10y$7,349.60$9,798.13
Total dividends collected$44.6K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WMMCX vs MRK ($10,000, DRIP)

YearWMMCX PortfolioWMMCX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,782$2,082.16$11,206$366.19+$1.6KWMMCX
2$16,164$2,487.34$12,650$502.35+$3.5KWMMCX
3$20,235$2,939.70$14,407$694.19+$5.8KWMMCX
4$25,091$3,439.35$16,585$967.82+$8.5KWMMCX
5$30,833$3,985.68$19,342$1,363.89+$11.5KWMMCX
6$37,569$4,577.37$22,913$1,947.19+$14.7KWMMCX
7$45,411$5,212.45$27,662$2,823.89+$17.7KWMMCX
8$54,478$5,888.33$34,159$4,173.35+$20.3KWMMCX
9$64,894$6,601.90$43,337$6,308.80+$21.6KWMMCX
10$76,786$7,349.60$56,776$9,798.13+$20.0KWMMCX

WMMCX vs MRK: Complete Analysis 2026

WMMCXStock

The investment seeks long term capital appreciation. The fund primarily invests in common stocks of smaller companies that have a market capitalization of $500 million or less at the time of the fund&#39;s initial investment. It focuses on micro-cap companies which appear to be underpriced relative to their "private market value." Private market value is the value which the sub-adviser believes informed investors would be willing to pay to acquire a company. The fund may also invest up to 25% of its total assets in foreign securities and in European Depositary Receipts ("EDRs") or American Depositary Receipts ("ADRs").

Full WMMCX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this WMMCX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WMMCX vs SCHDWMMCX vs JEPIWMMCX vs OWMMCX vs KOWMMCX vs MAINWMMCX vs JNJWMMCX vs ABBVWMMCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.